IRIS PubliCatt

D'Alo', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.148
EU - Europa 3.855
AS - Asia 1.084
OC - Oceania 73
AF - Africa 38
SA - Sud America 36
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.068
DE - Germania 1.602
CN - Cina 795
SE - Svezia 586
IT - Italia 402
UA - Ucraina 298
PL - Polonia 224
GB - Regno Unito 188
FR - Francia 182
IE - Irlanda 137
IN - India 110
CA - Canada 68
FI - Finlandia 66
AU - Australia 65
TR - Turchia 46
CI - Costa d'Avorio 25
IR - Iran 21
BR - Brasile 18
RO - Romania 18
BE - Belgio 16
JP - Giappone 16
NL - Olanda 15
RU - Federazione Russa 14
VN - Vietnam 14
CH - Svizzera 13
ES - Italia 12
AT - Austria 11
SG - Singapore 11
ID - Indonesia 10
MX - Messico 10
HU - Ungheria 9
IL - Israele 9
NO - Norvegia 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
CZ - Repubblica Ceca 7
HK - Hong Kong 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
KR - Corea 6
SK - Slovacchia (Repubblica Slovacca) 6
AR - Argentina 5
CO - Colombia 5
TH - Thailandia 5
HR - Croazia 4
NP - Nepal 4
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
LB - Libano 3
LV - Lettonia 3
MA - Marocco 3
RS - Serbia 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
CL - Cile 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
IS - Islanda 2
MK - Macedonia 2
PK - Pakistan 2
SA - Arabia Saudita 2
UY - Uruguay 2
ZA - Sudafrica 2
A1 - Anonimo 1
BD - Bangladesh 1
BO - Bolivia 1
DZ - Algeria 1
EU - Europa 1
GH - Ghana 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
PH - Filippine 1
PY - Paraguay 1
SC - Seychelles 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 9.236
Salva come PNG Salva come JPEG
Città #
Chandler 622
Ashburn 285
Jacksonville 232
Warsaw 208
Beijing 186
Houston 158
Nanjing 157
Dearborn 147
San Mateo 141
Ann Arbor 139
Woodbridge 135
Dublin 133
Fairfield 129
Wilmington 111
Nürnberg 108
Hangzhou 103
Milan 99
Redwood City 93
New York 85
Seattle 84
Bremen 67
Nanchang 58
Lawrence 52
Cattolica 50
Boston 44
Los Angeles 44
Rome 38
Kunming 36
Chicago 35
Izmir 35
Marseille 34
Munich 33
Lancaster 30
Cambridge 29
Abidjan 25
Guangzhou 25
Shenyang 25
Shanghai 24
Hebei 20
Hefei 20
Leawood 20
Auburn Hills 19
Fremont 19
Princeton 19
Brisbane 18
Changsha 18
Jiaxing 18
Mountain View 17
University Park 16
Brooklyn 15
Redmond 15
Tianjin 15
Zhengzhou 15
Norwalk 14
Brussels 13
Jinan 13
Berlin 11
Boardman 11
London 11
Philadelphia 11
Pune 11
Sydney 11
Augusta 10
Costa Mesa 10
Phoenix 10
San Diego 10
Hanoi 9
Hermosillo 9
Lanzhou 9
Chengdu 8
Falls Church 8
Monmouth Junction 8
Portland 8
San Jose 8
Helsinki 7
Hyderabad 7
Kish 7
Naples 7
San Francisco 7
San Martino Buon Albergo 7
Toronto 7
Adelaide 6
Andover 6
Atlanta 6
Buffalo 6
Canberra 6
Denver 6
Detroit 6
Enterprise 6
Lomazzo 6
McKinney 6
Padova 6
Romainville 6
Simi Valley 6
Traverse City 6
Vienna 6
Wroclaw 6
Alghero 5
Auckland 5
Burton 5
Totale 4.676
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 1.468
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 346
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 277
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 257
DNMT1-interacting RNAs block gene-specific DNA methylation 247
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 222
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 201
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 195
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 174
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 163
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 159
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 158
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 158
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 150
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 142
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 139
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 130
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 130
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 129
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 128
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 126
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 122
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 120
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 119
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 118
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 115
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 114
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 114
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 108
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 108
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 106
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 101
Epigenetic changes in therapy-related MDS/AML 98
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 98
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 97
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 95
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 93
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 93
Outcome of therapy-related myeloid neoplasms treated with azacitidine 90
PU.1 and CEBPA expression in acute myeloid leukemia. 89
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 89
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 89
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 88
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 88
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 85
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 85
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 85
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 84
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 84
Mantle cell lymphoma relapsing at the lymphedematous arm 81
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 81
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 80
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 79
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 79
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 75
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 74
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 72
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 72
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 72
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 71
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 68
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 67
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 66
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 61
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 59
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing 52
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 48
Secondary Orbital and Intraocular Lymphoma Treated With Immunochemotherapy 47
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 45
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 43
Absence of structural mutations of the BAK gene in B cell lymphomas 42
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 36
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 2
Totale 9.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019200 0 0 0 0 0 0 0 0 0 0 124 76
2019/20201.783 259 303 124 120 144 172 131 66 128 107 134 95
2020/20211.169 42 99 46 102 110 114 125 34 109 87 257 44
2021/2022852 106 84 14 26 66 36 26 128 53 72 114 127
2022/20231.797 241 254 128 310 107 211 92 141 176 27 67 43
2023/20241.178 49 249 68 81 110 189 76 107 80 149 20 0
Totale 9.346